DOI: 10.36347/sasjm.2023.v09i06.026

Pages: 690-693

The aim was to measure the life quality of patients with age-related macular degeneration. The survey included patients with age-related macular degeneration, aged 65 years and older. Recruitment of participants was performed from the preoperative consultation at the adult ophthalmology department. Investigation sheets containing socio-demographic, clinical data and the Moroccan version of the NEI VFQ25 quality of life questionnaire; were handed out to each patient. The association of the scores with the visual acuity was studied using the correlation coefficients. A total of 75 patients were enrolled including 56% women and 44% men and an average time of 3 .6 years since diagnosis of age-related macular degeneration with a mean age of of 76.9 ± 6.2 years. Average visual acuity (VA) in the better eye is 6/10 and 2/10 in the worse eye. The mean global VFQ-25 score was 48.7 ± 24.8. The significant public health burden of AMD includes both its negative effects on quality of life and on the economy. AMD causes a marked decrease in quality of life, underestimated by many, including physicians who regularly treat patients with AMD.